ABSTRACT
Background: Atrial fibrillation (AF) and hypertensive heart failure (HHF) frequently co-exist, causing increased morbidity and mortality. While inflammation is a recognized driver of AF in Western populations, there is a paucity of data regarding the role of c-reactive protein (CRP) in African participants with HHF and AF.
Aim: To compare the level of serum C-reactive protein in hypertensive heart failure patients with atrial fibrillation, those in sinus rhythm and apparently normal individuals.
Methods: This hospital-based cross-sectional comparative study involved 180 participants divided into three groups (n=60 each): HHF with AF, HHF without AF, and apparently healthy controls. Participants underwent clinical evaluation, 12-lead electrocardiography, transthoracic echocardiography, and high-sensitivity CRP (hs-CRP) analysis.
Results: The mean ages of HHF with AF, HHF without AF, and apparently healthy participants were 65.3 ± 9.9years, 66.7 ± 9.7 years, and 64.3 ± 10.5 years, respectively. The concentration of CRP was significantly higher in the HHF without AF compared to HF with AF and the apparently normal controls (p<0.001). CRP correlated positively with left ventricular internal diameters and volumes (p < 0.001), and inversely with ejection fraction (r = -0.279, p < 0.001). Multivariate regression identified left atrial diameter (OR 2.26, p = 0.02) and
ejection fraction (OR 4.02, p = 0.04) as independent predictors of AF, while CRP was not.
Conclusion: Serum CRP was not significantly elevated in HHF participantswith AF compared to those without AF. These findings may suggest that elevated CRP, a surrogate marker for inflammation, is not the primary pathophysiological pathway for AF in this population. However, results may have been influenced by confounding factors such as the use of guideline-directed medical treatment
for hypertension and HF.
Keyword: Hypertension, Heart failure, Inflammation, Atrial fibrillation, C-Reactive protein.